High-cost Angiotensin-Converting Enzyme (ACE) inhibitors
Presentations contributing to variation
In the quarter ending Nov 2022, the numerator in this measure was composed of the following presentations:
Download this data
Do you need help with your analysis? Don't forget to check the FAQ page
, and get in touch
if you have questions.